AXCELIS ANNOUNCES MULTIPLE SHIPMENTS OF PURION H200 Si and SiC POWER SERIES IMPLANTERS

Rhea-AI Summary

Axcelis Technologies (Nasdaq: ACLS) has announced significant progress in the power device segment with multiple shipments of its Purion H200 Si 200mm and SiC Power Series™ 150mm high current implanters to major power device chipmakers in Asia. These systems are intended for high-volume production in the automotive sector, which is experiencing rapid growth.

Executive Vice President Bill Bintz stated that the power device segment is projected to comprise 30% to 40% of their system sales in 2022, highlighting the company's commitment to support electric vehicle technology through advanced manufacturing solutions.

Positive

• Shipments of Purion H200 Si and SiC Power Series™ implanters to leading chipmakers indicate strong demand.
• Projected growth of 30% to 40% in power device segment sales for 2022.

Negative

• None.

News Market Reaction – ACLS

+0.88%

+0.88% Session move

In the trading session that priced this news, ACLS gained 0.88%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Axcelis' Leadership in the Power Device Segment Continues to Expand

BEVERLY, Mass., June 23, 2022 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, today announced multiple shipments of the Company's Purion H200 Si 200mm and SiC Power Series™ 150mm high current implanters to leading power device chipmakers. The shipments, which included two new penetrations and a follow-on order, went to fabs located in Asia. These customers will use the systems in high volume production of power devices supporting automotive device markets.

Executive Vice President of Product Development, Bill Bintz, commented, "Axcelis is committed to delivering best in class solutions that support the global adoption of EV technology, which is one of the fastest growing segments in IC manufacturing. Increasing automotive power device content is fueling particularly high growth in the power market. The Purion product portfolio is uniquely positioned to cover all current and emerging implant applications for this market segment. In 2022 we expect the power device segment to account for between 30% and 40% of our systems sales, and we expect continued growth in this segment."

About Axcelis:
Axcelis (Nasdaq: ACLS), headquartered in Beverly, Mass., has been providing innovative, high-productivity solutions for the semiconductor industry for 40 years. Axcelis is dedicated to developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation systems, one of the most critical and enabling steps in the IC manufacturing process. Learn more about Axcelis at www.axcelis.com.

CONTACTS:
Maureen Hart (editorial/media) 978.787.4266
Doug Lawson (investor relations) 978.787.9552

View original content to download multimedia:https://www.prnewswire.com/news-releases/axcelis-announces-multiple-shipments-of-purion-h200-si-and-sic-power-series-implanters-301573861.html

SOURCE Axcelis Technologies, Inc.

FAQ

What recent shipments did Axcelis announce on June 23, 2022?

Axcelis announced shipments of Purion H200 Si 200mm and SiC Power Series™ 150mm high current implanters to major power device chipmakers in Asia.

How much of Axcelis' sales is expected to come from the power device segment in 2022?

The power device segment is expected to account for 30% to 40% of Axcelis' sales in 2022.

Which markets are the Purion systems intended to support?

The Purion systems are intended for high volume production of power devices supporting automotive markets.

Who is the Executive Vice President of Axcelis Technologies?

Bill Bintz is the Executive Vice President of Product Development at Axcelis Technologies.